MUHC research news
McGill University Health Centre (MUHC) heart specialists are the first in Quebec (and the second in North America) to implant a fully automatic biventricular cardiac resynchronization therapy defibrillator. While continuously working to “pace” the patient’s heart, this “smart” technology allows the defibrillator to adjust itself automatically if it senses any change in the patient’s c
For a long time, the main obstacle to creating an AIDS vaccine has been the high genetic variability of the HIV virus. Dr. Jean-Pierre Routy and his team from the Research Institute of the McGill University Health Centre (MUHC), in collaboration with Dr. Rafick Sékaly from the Université de Montréal, have overcome this difficulty by designing a personalized immunotherapy for infected patients.
MUHC/McGill and CHUM researchers uncover key theoretical mechanism behind regenerative therapies for diabetes.
The Director of the Research Instituteof the MUHC elected to the Académie nationale de médecine in France
The achievements realised during his career as a researcher by Dr. Vassilios Papadopoulos, Director of the Research Institute of the McGill University Health Centre (MUHC) and Associate Executive Director of the MUHC, have once again been recognized and rewarded internationally
Enough is enough! Québec Coalition for Universal Newborn Hearing Screening calls on the minister of health to fund such a program now!
Researchers at the McGill University Health Centre (MUHC), McGill University and the University of British Columbia (UBC) determined that medical use of cannabinoids do not cause an increase in serious adverse events, but are associated with an increase in some non-serious adverse events.
Pediatric surgeon, Christo Tchervenkov has a global dream; he wants to keep the hearts of all children – no matter where they were born - beating.
Members of the media are invited to attend one of the fitting sessions to take place over the next four weeks, and to learn more about this crucial step in the MUHC’s larger plan for infection control.
Dr. Pierre Chartrand, Acting President of the Canadian Institutes of Health Research (CIHR), along with CIHR's Governing Council, made the announcment today.